| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Medicine, Northwestern University Medical School, Chicago, IL 60611;
Veteran’s Administration Chicago Health Care System, Lakeside Division, Chicago, IL 60611;
Departments of Medicine and Pathology and
§
University of Michigan Medical Center, Ann Arbor, MI 48109; and
¶
Theodor Kocher Institute, University of Bern, Bern, Switzerland
The chemokine, epithelial neutrophil-activating peptide-78 (ENA-78), is a potent neutrophil chemotaxin whose expression is increased in inflamed synovial tissue and fluid in human rheumatoid arthritis compared with osteoarthritis. Since ENA-78 has been implicated in the pathogenesis of RA, we examined the expression of an ENA-78-like protein during the development of rat adjuvant-induced arthritis (AIA). Using an ELISA assay, we found increased levels of antigenic ENA-78-like protein in the sera of AIA animals compared with control normal animals by day 7 postadjuvant injection. ENA-78-like protein levels continued to increase as AIA developed. ENA-78-like protein levels in joint homogenates were increased in AIA animals later in the development of the disease, by day 18 during maximal arthritis, compared with control animals. Expression of ENA-78-like protein in both the AIA serum and joint correlated with the progression of inflammation of the joints. Anti-human ENA-78 administered before disease onset modified the severity of AIA, while administration of anti-ENA-78 after clinical onset of AIA did not modify the disease. These data support a role for an ENA-78-like protein as an important chemokine in the progression and maintenance of AIA.
This article has been cited by other articles:
|
|
 |
|
  G-N. Liu, H-Z. Shi, Z-H. Xie, H-H. Shen, H-Q. Huang, J-M. Deng, Q-L. Liang, and Y-B. Wu Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion Eur. Respir. J., July 1, 2009; 34(1): 184 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-M. Noh, J.-S. Kim, H. Hur, B.-H. Park, E.-K. Song, M.-K. Han, K.-B. Kwon, W.-H. Yoo, I.-K. Shim, S. J. Lee, et al. Cordycepin inhibits IL-1{beta}-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts Rheumatology, January 1, 2009; 48(1): 45 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Lehmann, A. M. P. B. Seneviratne, and A. V. Smrcka Small Molecule Disruption of G Protein {beta}{gamma} Subunit Signaling Inhibits Neutrophil Chemotaxis and Inflammation Mol. Pharmacol., February 1, 2008; 73(2): 410 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rajashekhar, M. Grow, A. Willuweit, C. E. Patterson, and M. Clauss Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation Physiol Genomics, September 11, 2007; 31(1): 104 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nanki, Y. Urasaki, T. Imai, M. Nishimura, K. Muramoto, T. Kubota, and N. Miyasaka Inhibition of Fractalkine Ameliorates Murine Collagen-Induced Arthritis J. Immunol., December 1, 2004; 173(11): 7010 - 7016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Haringman, J Ludikhuize, and P P Tak Chemokines in joint disease: the key to inflammation? Ann Rheum Dis, October 1, 2004; 63(10): 1186 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ruddy, F. Shen, J. B. Smith, A. Sharma, and S. L. Gaffen Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment J. Leukoc. Biol., July 1, 2004; 76(1): 135 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Tchetverikov, L R Lard, J DeGroot, N Verzijl, J M TeKoppele, F C Breedveld, T W J Huizinga, and R Hanemaaijer Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis Ann Rheum Dis, November 1, 2003; 62(11): 1094 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. KEANE, J. A. BELPERIO, M. D. BURDICK, J. P. LYNCH III, M. C. FISHBEIN, and R. M. STRIETER ENA-78 Is an Important Angiogenic Factor in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2239 - 2242. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
